CytoDyn Inc (QB) (CYDY) Quote

The show must go on! Are there any real housewives left in America? They used to be glued to the boob tube watching "As The World Turns".
Personally, I am hoping for a novella called "Leronlimab Ladies Live And Well" starring the Pour Brothers. Maybe the "Adventures of CytoDyn" would increase
the chance for returning seasons. Murray, Birnkrant, Sheikh, Strayhorn, Akunne, Winestrock, Struble et al, still looking for actors to play their juicy parts.
Surely stands a chance to beat out All My Children anyway.

Dr. Kildaire or Make Us Welby, MD actors could fit right in, but I vote for Katangolo. What say? This could be a real cash cow providing the big bucks for more trials... medical that is, hopefully not legal thanks to Dr. Jay in the lead role now.

Yippers, $CYDY$ 2024 The New Beginning is unfolding right on cue. Lights, camera, action. 🤠

ok, thanks for that clarification. that would further bolster the economic case of that offering serving as a lid on the SP.

Ideally next week, post-transaction, we get either (i) a jump in the SP, or (ii) CC announcement from Jay. Actually, i'll take both !

Achhhuallly CYDY hasnt run a trial in years

Hey loooongs how's it going? Sticking it to the shorts eh?

RE: FDA Communications
Anyone recall the two fda bureaucrats that bad mouthed CytoDyn? Are they on the list.

Also note..."with the understanding we are not limiting our list by doing so".


I also wonder who is the redacted person in the heading?

Interesting the pps is up 8% this past week or so. Where are the 13D shorts?
Are some of them buying warrants or covering short positions or both?
Could be they finally see the light that Dr. Jay turned on.

Actually, the EXACT price of the warrant conversion is $.09387 per warrant to get 1 share plus a 20% bonus share bringing the cost down to $.078225 per share. And yes I believe the deal closes by this Friday.

The warrant exchange deal closes Friday, at least that's my understanding. My theory has been that this has put pressure on the SP, as people sold shares at .14 to buy (exercise warrants) at .09. But, i could be wrong and we'll find out next week if there is anything to that theory.

Aside from that, what we really need is to hear from Jay. A lot has happened since the last call in terms of new trials / protocols, etc. - and obviously cash in the bank from the Amarex settlement and this warrant exchange.

Jay should address shareholders and frame these events - I would think he'd be chomping at the bit, as these are all positive developments (especially the cash in the bank). He should also give projections on the timetables as to when all of these trials could begin to deliver data, which ones could lead to a partnership, etc.

Personally, I think we need some explanation as to why the stock remains at all time lows here - and when we we might expect to see some recovery.

Interesting that you seem to know what I'm doing or not doing. Or that you even care. I need to spend money and sign up so I can see the day by day activity of the NP/KK case so I can do what, exactly? How does that have anything to do with CYDY? I'll just stick to looking for the things that matter for the trajectory of the company now in the present. Seems more productive to me.

Interesting that you still will not get off your **** and look for facts.

Um, ok. Don't know what all that's about. What a smartass. Thank you, oh great one for gracing us with this information. I'll gladly sit in the cheap seats since I'm not paying for access to Pacer or anything else like that. It's not pertinent to anything that I do. Interesting that it's that old and was just posted.

Many understand your frustration for instant gratification.

These PACER posting were made on 2024/07/15, so I guess you'll have to take that up with the US Court's reporting system.

Or better yet, why not contact Judge Xinis directly and ask her to provide you with free and prompt reporting of court documents. I'm sure she'd understand your frustrations and indulge you.

Withstanding that, I guess you'll have to just sit with everyone else in the cheap seats watching the show.

#3 and #17--probably would pay to be called as a witness

#2 and # 6--might do the same, just as eager to testify against DR pourhassan

#14 and # 22--probably could not find any persons less credible unless lonsford

Yes, and that was from March going into April. Any new news? It's now July.

New updates in the NP/KK vs USA case files. Seems that the Government witness list has been shared between parties.

Anyone see names blatantly absent amongst all the other CytoDyn smiling faces ?

You guessed it - SK and AC.

"leronlimab could be paired with checkpoint inhibitors like Merck & Co.’s Keytruda, Bristol Myers Squibb’s Opdivo or Roche’s Tecentriq. The plan likens leronlimab to Bristol Myers’ Yervoy, which is often paired with Opdivo. The Big Pharma collects about $1.5 billion a year from the therapy’s combination approvals.

These partner therapies, called immune control point (ICI) inhibitors, act when the tumor begins to resist the main treatment, reactivating the immune system to extend the anti-tumor response.

CytoDyn could capitalize on the popularity of combination treatment trials, which are all the rage in oncology at the moment. They suggest that leronlimab would perform the same duty as an ICI, basing their argument on data from previous COVID-19 and HIV trials that suggest the drug can reverse T-cell exhaustion.

“Leronlimab has an opportunity to be a major replacement option for ICI’s due to toxicity concerns,”

The therapy avoids major side effects associated with this type of treatment such as pituitary disorders and organ dysfunction, according to the plan. Leronlimab may have opportunity in lung, breast, pancreatic, urothelial and colorectal cancers.

Wonder if this....." suggests that CytoDyn seek out partnerships with Bristol Myers, Roche, AstraZeneca, Pfizer and Regeneron to negotiate potential clinical trial combinations.

“These companies should be amenable to clinical investigation into leronlimab combination once leronlimab proves its efficacy as a CCR5 inhibitor,”

From a couple of years ago. Would any of this is being presently contemplated since we have official word that partnerships are in the hopper. Go Dr. Jay and Team CytoDyn.

ONE other note... would so love to hear about the Pour Brothers trial. I used to love sitting in on trials hearing first hand testimony. Will those derelicts from the fda that spouted out their hate for CytoDyn be testifying? Hopefully they will be dragged through the mud no matter the trial outcome. Transparency matters. EUA should have been granted or at a minimum Expanded Use/Compassionate Use should have been maintained. At least Erap ex president Philippines was saved.

"Expanded access, or compassionate use, is an individual patient use of an investigational new drug outside of a clinical trial. Expanded access is sometimes possible when the investigational new drug is needed to treat a serious or life-threatening condition and there is some clinical evidence suggesting that it might be effective in that condition." So so many ways the official health agencies conspired to harm the public. Sad sad sad.

Yawn dead stock for zombie company is boring now. Bring back Nader.

Is that short for Delivery Boy? Well, whatever!
All have a blessed weekend.
TICK TICK TICK ..... money in the bank and trials in the works together with some new pharma company raring to go.

Okay, Del, we hear you, loud and clear. Check out who Del is?

Would guess weed wine is selling as fast as possible--now he doesn't have to report as insider. IF CYDY is not paying nodder legal--same for that disgusting filth

Selling shares at 13-14 cents then getting shares in the 8-9 cent range and maybe selling those also??

Dr Jay was left with crap hand of cards. From years and years of shareholders/mngmt/pumpers posting lies/voting and allowing fraud to proliferate

Cytta Corp live
July 12th 12noon edt





https://campaigns-events.was-1.onpdr.com/track/link/v2_0q9wlbrxgd/4nfi1ukgbo2kxuthewymg2cm0/v2_gwv14w6dk7 (https://campaigns-events.was-1.onpdr.com/track/link/v2_0q9wlbrxgd/4nfi1ukgbo2kxuthewymg2cm0/v2_gwv14w6dk7)

How confusing is it the dilution hasn't stopped look at the float. And they are a clinical stage biotech not running any trials. I'm actually shocked they've managed to keep it this high.

I am truly perplexed by the SP action here. The fact that we're trading lower than before the hold was lifted, and before the Amarex settlement makes no sense to me. Because those were the 2 big unknowns (inability to run trials and solvency) clouding the future of the company - they've now been resolved, and the SP is.......lower? It's like the Twilight Zone.

My only explanation is that people are selling long shares to raise cash to exercise their warrants at the 9 cent range. And I can imagine that's driving the SP, because volume is so low there's clearly not any buying of size on the other side of the table.

Still, It's pretty damn frustrating I have to say.

BlackOps is not dead. I spoke to him recently and is enjoying his retirement.
No doubt he is enjoying it much (much) more than his CYDY investment. He got destroyed.

https://stockanalysis.com/stocks/cydy/
"The terms of the settlement provide an immediate influx of non-dilutive cash and eliminates $14 million of accounts payable. Importantly, the settlement ends the potential distraction and uncertainty associated with protracted litigation and allows the Company to immediately advance its clinical trials and research and development initiatives, said Dr. Jacob Lalezari, CEO.”

TIck TIck Tick..... Sidley pre-paid, thanks!, 6.5 $$$ million bond released, thanks!,14$$milly eliminated, thanks!, 12$$ milly influx, thanks Kareem, 32.5 $$ milly credited to our account!! Plus the earlier Samsung agreement... I WOULD SAY WE ARE GOOD TO GO TRIAL WISE!! new partner ???

$$CYDY$$ 2024

VANCOUVER, Washington, June 27, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that its preclinical MASH study with SMC Laboratories, Inc. (“SMC”) has commenced, with results expected in the fall of 2024.

CytoDyn believes its prior MASH study demonstrated a statistically significant benefit of leronlimab at a dosing level of 350 mg. To clarify the optimal dosing and evaluate the potential for combination therapy, SMC will be conducting a twelve-week preclinical mouse study evaluating both 350 and 700 mg dose levels, alone and in combination with Resmetirom, a drug recently approved by the FDA. The study will evaluate leronlimab’s potential role in preventing and/or reversing liver fibrosis.

CytoDyn’s CEO, Dr. Jacob Lalezari, stated, “in addition to clarifying dosing and efficacy, the goal of this study is to eventually use the results to pursue partnerships in the MASH space. Although CytoDyn will be primarily focused on oncology and inflammation in the coming months, we do believe that leronlimab could have a significant role in the treatment of MASH, whether as a standalone therapeutic or in a combination therapy approach.”

Misiu sent me a note and straightened me out. I apologize.

Lol reddit how many times have those fools been right? Oh yeah... ZERO!!!
Also, do you seriously believe CYDY would sue the FDA? I mean come on this is loonyville right now absolutely delusional.

Why even write that stuff. Speculation! BlackOps is not dead. I spoke to him recently and is enjoying his retirement.

Shame. Thanks.

Only speculation. A few posters thought he may have passed on. He told me that he was very old.

Yeah that is it thanks. Any idea what happened to him?

BlackOps?

Anyone remember the alias of the guy who posted a few years back a fair amount. Older. Trader back in the day. Always dropping stories about deals he had been in on. Has not posted in a long time.

So either the results of the Thai Red Cross AIDS PrEP trial--so after a 5 year followup on RCT patients
https://www.biospectrumasia.com/news/56/13786/cytodyn-signs-mou-with-thai-red-cross-aids-research-centre-.html

Or it could be the other "partner" that "Dr" pourhassan mentions in this interview. He speaks of 2 (sure 1 was Vyera) so time for the other to step up. Around the 4 min mark: https://audioboom.com/posts/7348426-cytodyn-joins-the-stock-day-podcast-to-discuss-phase-3-trials-for-their-hiv-program

Possibly according to several @ Redditt there are partnerships that are waiting to begin as soon as hold is lifted. And there are other partnerships to begin as soon as the amawrecks legal issue is settled. Possibly no other catalysts are needed as several have posted along with CYDY mngmt that the dollar amount could be 100 million. SidleyAustin will advise on this legal matter to assure full value.

There are also red thread experts that believe CYDY should pursue full damages against the FDA. Also liability may extend to Brazil, Lonza, fax machines, Mahboob Rahman, Dr Pestell, Brial Brothen,Dr Patterson,Sharp packaging, and Tony Caracciolo

Ouch so what's the next cydy catalyst?

Dr Sacha monkeys might get jealous (Dr Sacha nervous about his gravy train??)

https://www.sciencealert.com/new-hiv-prevention-drug-shows-100-efficacy-in-clinical-trial

CYDY in the news
https://www.bizjournals.com/portland/news/2024/07/09/cytodyn-amarex-settle-12-million.html

Their coverage 7 months ago: https://www.bizjournals.com/portland/news/2024/01/31/investors-file-another-lawsuit-against-cytodyn.html

Jay is a mover and shaker. I like his fighting spirit and savvy as to how the health system functions and malfunctions. This is the leadership we have needed to advance leronlimab. With his team we have seen great strides in the past year. The PPS is going to go nuts when new trials begin.

We all know it's coming especially the shorts. There will be some big money entering the scene which will set off a short squeeze. Some large buys are being noted. Whether the pps goes up or down a few points with the same typical volume is meaningless. Yesterday especially but for the past week or so, the pps has steadily inched up having observed a changing behavior. Astute and aware traders and investors are again entering. On this forum we will see some new faces appear and some others from the past return. We all have known it is just a matter of time, those who truly know and appreciate our candidate leronlimab.

The recognition of the sthenic immense talent of Dr. Jay Lalezari by Board Chair Tanya Urbach has been key to this turn around. Leadership is everything. With leronlimab as our product great advances are in store. We are truly blessed to be part of this history.

This is a good time to re-familiarize with all the talent we possess. Read the website and know those involved in your company. Know what you own. $CYDY$ 2024

$CYDY
$CYDY Testing the 200 day MA.. a move above it could trigger an even bigger move as it had a history of it… pic.twitter.com/7GQ1v4HWMo— Chris from Massachusetts AKA TommyboyTrader (@autumnsdad1) July 10, 2024

Looks like you were right. Nice for $12M, let’s hope they do something good with it.

Its not about "seeing" the 8-K. Its about having some situational awareness (read common sense) and being able to source outside a branch davidian cultness

There have been several informed persons speaking to "binding arbitration" for months (even 1 guy at thangout)
There have been postings of the MSA with amawrecks showing the binding arbitration clause (back to 2021)
Its not news

But be glad the settle went toward shareholders. I am sure you never saw some of the covenants of the Welch bond. I.E.
If CytoDyn is required to pay any amounts to Amarex in connection with the Amarex Litigation or the Amarex Arbitration, CytoDyn shall use commercially reasonable efforts to immediately pay or structure a settlement with Amarex such that no claim is submitted by Amarex against the Surety Bond.

Never even crossed your mind?? "Pat" yourself on the back

Oh wowww, why isn’t your power still off???

Kobe is back for good???

Nice to see you…

In other news,,, I really enjoy this quote from the Pres Release.

“Importantly, the settlement ends the potential distraction and uncertainty associated with protracted litigation and allows the Company to immediately advance its clinical trials and research and development initiatives”

Sounds like it’s clearing Fear,,, Uncertainty,,, and Doubt…

Lol owned in the face long keep getting stuff wrong I will keep laughing

It looks like you are correct about the end of legal liabilities. I hadn't seen the 8-K yet. Still, they should be able to move forward with their clinical trials.

I think it is pretty amazing that hardly any of you guys can post without being a total smartass. It makes you sound like a pre adolescent on a playground. You should really consider growing up. I'm sure your family isn't too proud of you. I doubt that is the way you were raised.

I love love love watching longs try to comfort each other and make sense of the fact that their terrible investment didnt take off after winning a measly 14 mil. Oh boy do I enjoy this so. Keep it coming longs!

You really are as dumb as they come. It's over they got 14 mil period done no more bye bye

there you go, Jazzy is to Jazzied to think of that- civil suit

The arbitration is what was settled. I believe the door is still open for a lawsuit seeking compensation for damages caused by Amarex's sub standard work.

What the hell are you talking about they literally settled my god you longs are dumb

You think the lawsuit is done? I'm going to go with think again

Remember when they said 100 million and you believed them?